TNF Inhibitors
Showing 1 - 25 of 5,521
Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in
Not yet recruiting
- Rheumatoid Arthritis
- Observation
- (no location specified)
Oct 8, 2022
Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)
Not yet recruiting
- Tuberculous Meningitis
- HIV I Infection
- Adalimumab Injection
-
Rio De Janeiro, Brazil
- +2 more
Jan 31, 2023
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment
Recruiting
- Arthritis, Rheumatoid
- +2 more
-
Aalborg, DenmarkDepartment of rheumatology
Sep 1, 2022
HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive
Recruiting
- Drug Monitoring
- Inflammatory Bowel Diseases
- Tumor necrosis factor (TNF)-alpha inhibitors
-
Valladolid, SpainHospital Universitario Rio Hortega
Aug 8, 2023
Rheumatoid Arthritis Trial in New York (TNF inhibitors, DMARDs)
Completed
- Rheumatoid Arthritis
- TNF inhibitors
- DMARDs
-
New York, New YorkColumbia University Medical Center
Nov 4, 2020
Rheumatoid Arthritis Trial in Norway (TNF inhibitors, Synthetic DMARD(s), Co-medication: Synthetic DMARDs)
Active, not recruiting
- Rheumatoid Arthritis
- TNF inhibitors
- +2 more
-
Bergen, Norway
- +9 more
Sep 14, 2020
Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))
Not yet recruiting
- Rheumatoid Arthritis
- Abatacept (M3-M12)
- +2 more
-
Montpellier, FranceCentre Hospitalier Universitaire de Montpellier
Jun 16, 2022
The Clinical Features and Pregnancy Outcomes of RA Patients
Recruiting
- Rheumatoid Arthritis
- Pregnancy Related
- Prednisone
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Dec 6, 2022
Colitis, Ulcerative Trial in Worldwide (Etrolizumab, Placebo)
Ulcerative Colitis Trial in Worldwide (Etrolizumab, Infliximab, Placebo (IV))
Noninterventional Examination of Subcutaneous Tumor Necrosis
Completed
- Rheumatoid Arthritis
-
Aachen, Germany
- +121 more
Dec 21, 2020
Ulcerative Colitis Trial in Worldwide (Adalimumab, Adalimumab Placebo, Etrolizumab)
TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Jun 17, 2022
Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)
Completed
- Crohn's Disease
- Ulcerative Colitis
- Immuno monitoring
-
Montpellier, FranceUniversity hospital
Dec 13, 2022
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])
Enrolling by invitation
- Lung Transplant; Complications
- Etanercept Injection [Enbrel]
-
Chicago, IllinoisNorthwestern University
Jul 10, 2023
T and B Cell Repertoire Changes in Response to Orencia® in
Recruiting
- Rheumatoid Arthritis
-
New York, New YorkHospital for Special Surgery
Mar 13, 2023
Blocking TNF to Potentiate ICI-dependent Immune Awakening in
Recruiting
- Melanoma
- +2 more
-
Toulouse, FranceInstitut Claudius Regaud
May 25, 2023
Golimumab in Ulcerative Colitis: Results ofReal-life Study in
Completed
- Ulcerative Colitis
- Flare Up, Symptom
- Exposure to golimumab
-
Zurich, SwitzerlandDivision of Gastroenterology, University Hospital Zurich
May 31, 2022
Rheumatoid Arthritis, Drug Use Trial in Hong Kong (biologic/targeted therapy)
Not yet recruiting
- Rheumatoid Arthritis
- Drug Use
- biologic/targeted therapy
-
Hong Kong, ChinaDepartment of Medicine, Tuen Mun Hospital
Jan 5, 2022
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Methotrexate, Adalimumab Injection)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 28, 2022